HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Magda M Melkonyan Selected Research

mesedin

1/2020α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin.
12/2017Neuroprotective, Neurogenic, and Amyloid Beta Reducing Effect of a Novel Alpha 2-Adrenoblocker, Mesedin, on Astroglia and Neuronal Progenitors upon Hypoxia and Glutamate Exposure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Magda M Melkonyan Research Topics

Disease

1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2021
1Huntington Disease (Huntington's Disease)
03/2021
1Parkinson Disease (Parkinson's Disease)
03/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Neuroinflammatory Diseases
12/2017
1Hypoxia (Hypoxemia)
12/2017

Drug/Important Bio-Agent (IBA)

2Adrenergic Receptors (Adrenergic Receptor)IBA
03/2021 - 01/2020
2mesedinIBA
01/2020 - 12/2017
1polyglutamineIBA
03/2021
1Glutamic Acid (Glutamate)FDA Link
12/2017
1Amyloid beta-PeptidesIBA
12/2017
1Amyloid (Amyloid Fibrils)IBA
12/2017
1Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2017